Skip to main content
Premium Trial:

Request an Annual Quote

Co-Diagnostics Posts Q1 Revenue Boost on SARS-CoV-2 Test Sales

NEW YORK — Co-Diagnostics on Thursday after the close of the market reported a massive jump in first quarter revenues, largely due to sales of its Logix Smart COVID-19 test for SARS-CoV-2.

For the three-month period ended March 31, Co-Diagnostics' revenues were $20.0 million, a more than 13-fold increase versus $1.5 million in the same period a year earlier.

Sales of the PCR-based Logix Smart test, which was CE-IVD marked in February 2020 and received Emergency Use Authorization from the US Food and Drug Administration shortly thereafter, accounted for most of those revenues.

Co-Diagnostics posted a first quarter net profit of $7.9 million, or $.26 per share, compared with a year-ago net loss of $1.1 million, or $.05 per share.

R&D spending in the quarter increased fivefold to $2.2 million from $400,022 the year before, reflecting the costs of developing a rapid point-of-care device for SARS-CoV-2 and other infectious diseases, as well as the impact of additional hires made to support the company's new product development activities.

SG&A expenses were up 141 percent to $4.1 million from $1.7 million, mostly due to increased compensation expenses.

At the end of March, Salt Lake City-based Co-Diagnostics had cash and cash equivalents of $57.8 million and marketable securities of $2.3 million.

Looking ahead, Co-Diagnostics said it expects second quarter revenues in the range of $20.0 million to $22.0 million, with earnings between $.19 and $.23 per share. Wall Street analysts, on average, are expecting $16.3 million in Q2 revenues.

In Friday morning trading on the Nasdaq, shares of Co-Diagnostics were up almost 11 percent at $7.93.

The Scan

Close Panel Vote on Califf Nomination

The New York Times reports there was a close committee vote to advance the nomination of Robert Califf to lead the US Food and Drug Administration to the full Senate.

Task Force Reports on Scientific Integrity

Nature News writes that that a new task force report recommends that the US establish a cross-agency scientific integrity council.

Across the Hall

Genetic testing, closed-circuit cameras, and more show how a traveler, without any contact, infected others at a New Zealand quarantine facility, CNN reports.

Science Paper Examines Influence of Chromatin Modifications on Obsessive-Compulsive Disorder

In Science this week: genes regulating chromatin modification may contribute to OCD risk.